Kolexia
Barbe Catherine
Médecine générale
Centre hospitalier de Tours
Tours, France
37 Activités
0 Followers

Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Tumeurs du sein Neuropathies périphériques Tumeurs du foie Métastase tumorale Prédisposition génétique à une maladie {{person.topmesh7.name}} {{person.topmesh8.name}} {{person.topmesh9.name}} {{person.topmesh10.name}}

Industries

Lilly
4 collaboration(s)
Dernière en 2022
AstraZeneca
3 collaboration(s)
Dernière en 2022
Ipsen
1 collaboration(s)
Dernière en 2020
Leo Pharma
1 collaboration(s)
Dernière en 2022

Dernières activités

Understanding Inequalities in the Uptake of Supportive Care to Improve Practices in the Cancer Care Continuum.
Cancers   08 décembre 2022
NEUROTAX: Involvement of SK3 Calcium Channel in Taxane Neuropathy
Essai Clinique (CHU Tours)   27 avril 2021
Long-term outcomes in patients with PET-predicted poor-responsive HER2-positive breast cancer treated with neoadjuvant bevacizumab added to trastuzumab and docetaxel: 5-year follow-up of the randomised Avataxher study.
EClinicalMedicine   04 novembre 2020
Cross-Cultural Adaptation and Psychometric Validation of the French Version of the FAMCARE-Patient (FFP-16) Questionnaire for Outpatients With Advanced-Stage Cancer.
Journal of pain and symptom management   21 février 2020
KALICOU3: Evaluation of the Impact of Emotional Skills of Young Women (≤ 45 Years), With Non-metastatic Breast Cancer, and Their Partner on Adjustment to Cancer
Essai Clinique (Centre Oscar-Lambret)   24 juin 2019
Medico-economic benefits of subcutaneous formulations of trastuzumab and rituximab in day hospitalisation (SCuBA Study).
Bulletin du cancer   21 septembre 2018
SK3 Gene Polymorphism Is Associated with Taxane Neurotoxicity and Cell Calcium Homeostasis.
Clinical cancer research : an official journal of the American Association for Cancer Research   23 juillet 2018
Prolonged complete response after treatment withdrawal in HER2-overexpressed, hormone receptor-negative breast cancer with liver metastases: the prospect of disappearance of an incurable disease.
BMC cancer   22 septembre 2014
{{person.lastact9.name}}
{{person.lastact9.jour}}   {{person.lastact9.date}}
{{person.lastact10.name}}
{{person.lastact10.jour}}   {{person.lastact10.date}}